Developing HIV vaccine feasible in near future, says NACA
The National Agency for the Control of AIDS (NACA) has said that although progress in Human Immuno-deficiency Virus (HIV) vaccine development by the scientific community continues to raise hope that one day this feat will be achieved, a lot of work is still required.
New HIV infections among pregnant women raise concerns
Concerns and fears have arisen over the gradual spike in the number of women that have tested positive to Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) in Lagos State.
Universal antibody drug for HIV-1 prevention, immunotherapy
Scientists have invented a universal antibody drug against Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS). By engineering a tandem bi-specific broadly neutralizing antibody, the team found that this novel antibody drug is universally effective not only against all genetically divergent global HIV-1 strains tested but also promoting the elimination of latently infected cells in…
Ending HIV, AIDS by 2030: NACA extends strategic outreach programme
The National Agency for the Control of AIDS (NACA) says it has further extended its Strategic Travelers’ Outreach Programme (STOP) to some West African states as one of the approaches aimed at ending HIV and AIDS in 2030.
Could this implant protect women from HIV?
Researchers in Canada have developed a vaginal implant that aims to protect women from becoming diagnosed with Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS).
Hope dims for Nigeria’s efforts to eliminate HIV, TB
The existing huge funding gap over 64 percent of the $336 million needed yearly to tackle Tuberculosis (TB) in Nigeria is threatening country’s target of eradicating tuberculosis by 2020. According to National TB Strategic Plan 2015-2020, about $2 billion us needed to tackle tuberculosis in the country. A breakdown of the amount indicates that about…
Monkeys provide new clues toward elusive HIV vaccine, cure
Despite enormous efforts over more than 30 years, Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) researchers have yet to develop either a vaccine or cure for the disease. But they have made progress in monkey experiments, and two studies reported this week at the largest annual United States....
Red alert to global slowdown in life expectancy gains
People's chances of living longer have been increasing dramatically for decades. But, that seems to have slowed recently, a new worldwide study has found.
‘Nigeria’s maternal mortality ratio is alarming’
I am Dr. Duduyemi Adeola Olawunmi, the programme officer, service delivery, with the Nigerian Urban Reproductive Health Initiative 2 (NURHI 2), an ongoing five-year family planning project in Lagos state.
Nigeria records 700 new HIV infections daily
Joint United Nations Programme on HIV/AIDS (UNAIDS) and the National Agency for Control of AIDS (NACA) have alerted that on daily basis, there are about 5,000 new Human Immuno-deficiency Virus (HIV) infections globally, out of which Nigeria contributes about 700 cases. They said Nigeria has the biggest HIV burden in West and Central Africa, representing…
Gene editing could cure HIV, end AIDS crisis
Experts say gene therapy could finally be used to treat Human Immuno-deficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) - after a decade of trying to replicate the transplant that cured a patient in Germany. Although there is no definitive cure for the disease, there have been many advances in treatment that have made…